Trans-Middle-Ear Mucosal Gas Exchange Project 1, Specific Aim 1
NCT01925482 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2019-02-19
Summary
This study will measure the speed at which gases move between the middle-ear air-space and the blood flowing through the middle-ear lining. The middle ear is a rigid biological gas pocket located behind the eardrum and is filled with the same gases as in air, primarily oxygen (O), nitrogen (N) and carbon dioxide (CO2), but in different proportions. The middle ear is lined by a thin layer of cells overlying tissues that surround blood vessels. The blood that flows through the middle-ear lining also contains these same gases but at different proportions from both the atmosphere (room air) and middle ear. Because of the differences in the proportions of these gases, each gas tends to flow between the middle ear and blood trying to make the proportions of gases in those compartments the same. This flow of gases to and from the middle ear changes the middle-ear pressure. If the middle-ear pressure decreases much below the air pressure of the atmosphere, the ability to hear sounds is impaired and fluid can build up in the middle ear. It is expected that each different gas will move between the middle ear and blood at a different speed, but it is not known what those speeds are for any of the gases. It is also expected that those speeds will be different for ears that have had middle-ear disease and those that have not. In this study, we will measure the speed of nitrogen, oxygen and carbon dioxide exchanges in both directions between the middle ear and blood. To do this, the gas mixture in the middle ear will be changed so that there is movement of only one gas for each experiment and then measure the change in the amount of the gas in the middle ear. This can be done using a special instrument called a mass spectrometer if there is an open, working tympanostomy (ventilation) tube, a small plastic tube, in the eardrum. For all participants in this study, we will conduct 6 experiments lasting about 2 hours each to measure the speed of nitrogen, oxygen and carbon dioxide flow. Subjects with and without tympanostomy tubes will be recruited. Those without a tube will have a tube inserted in one ear for study purposes and it will be removed at the end of the study; these subjects will be followed weekly until the hole in the eardrum (where the tube was) is closed.
Conditions
- Middle Ear Gas Exchange
Interventions
- DRUG
-
6%CO2, 25%O2, balance N2
exposure of middle ear to gas
- DRUG
-
6% CO2, 0%O2, balance N2
exposure of middle ear to gas
- DRUG
-
20%CO2, 6%O2, balance N2
exposure of middle ear to gas
- DRUG
-
0%CO2, 6%O2, balance N2
exposure of middle ear to gas
- DRUG
-
6% CO2, 6%O2, balance N2
exposure of middle ear to gas
- DRUG
-
6%CO2, 6%O2, 0%N2, balance argon
exposure of middle ear to gas
Sponsors & Collaborators
-
National Institute on Deafness and Other Communication Disorders (NIDCD)
collaborator NIH -
Cuneyt M. Alper
lead OTHER
Principal Investigators
-
Cuneyt M Alper, MD · University of Pittsburgh
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-05-13
- Primary Completion
- 2015-04-24
- Completion
- 2015-05-19
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population
NCT06293482 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Observation of Gas Exchange in the Middle Ear
NCT00794105 ·Status: UNKNOWN
-
Clinical Study of Cochlear Implants in Adults With Asymmetrical Hearing Loss
NCT02004535 ·Status: COMPLETED ·Phase: NA
-
Effect of Rate (Slope) of Compression on the Incidence of Symptomatic ETD and MEB: a Phase III Prospective Study.
NCT04804098 ·Status: RECRUITING ·Phase: NA
-
Coherent Optical Detection of Middle Ear Disease
NCT05353569 ·Status: RECRUITING ·Phase: NA
-
Anesthetizing the Tympanic Membrane in Healthy Volunteers
NCT01047904 ·Status: COMPLETED ·Phase: NA
-
The Effect of PAP on ISSHL Comorbided With OSA
NCT04192656 ·Status: RECRUITING ·Phase: PHASE4
-
Pretympanoplasty Assessment of Patency and Mucociliary Function of Eustachian Tube
NCT05229380 ·Status: UNKNOWN
-
Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing
NCT07254442 ·Status: COMPLETED
-
Efficacy of Tympanostomy Tubes for Children With Recurrent Acute Otitis Media
NCT02567825 ·Status: COMPLETED ·Phase: NA
-
Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss
NCT02038972 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
OTO-413 in Subjects With Speech-in-Noise Hearing Impairment
NCT04129775 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
TNF-α Treatment of Blast-Induced Tinnitus
NCT04066348 ·Status: RECRUITING ·Phase: PHASE2
-
Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss
NCT04766853 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of a Mastoid Device in Subjects With Ménière's Disease
NCT03520322 ·Status: TERMINATED ·Phase: NA
-
Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Meniere Disease
NCT04686695 ·Status: COMPLETED ·Phase: NA
-
SinuSonic for ETD and Facial Pain: Acoustic Vibration + Oscillating Expiratory Pressure
NCT04404036 ·Status: COMPLETED ·Phase: NA
-
Novel Tinnitus Implant System for the Treatment of Chronic Severe Tinnitus
NCT03988699 ·Status: COMPLETED ·Phase: NA
-
Cochlear Implantation in Adults With Asymmetric Hearing Loss Clinical Trial
NCT03052920 ·Status: COMPLETED ·Phase: NA
-
Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin
NCT05730283 ·Status: RECRUITING ·Phase: PHASE2
-
Performance and Safety of Otinova® Ear Spray
NCT05370209 ·Status: TERMINATED ·Phase: NA
-
Evaluation of the Tympanostomy Tube Delivery System
NCT01202578 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Antibiotic Concentration After Delivery to Middle Ear for Chronic Suppurative Otitis Media
NCT05133258 ·Status: COMPLETED
-
Inner and Middle Ear Effects of Hyperbaric Oxygen Thrapy
NCT04186741 ·Status: UNKNOWN
-
AM-101 in the Treatment of Acute Tinnitus 3
NCT02040194 ·Status: COMPLETED ·Phase: PHASE3